Navigation Links
Cepheid Schedules 2010 Third Quarter Financial Results Announcement and Webcast
Date:10/7/2010

SUNNYVALE, Calif., Oct. 7 /PRNewswire-FirstCall/ -- Cepheid today announced that it will report financial results for its third quarter ended September 30, 2010, on Thursday, October 21, 2010, after the close of the market.

The company will host a management presentation at 2 p.m. Pacific Time on Thursday, October 21, 2010, to discuss the results.  To access the live webcast, please visit Cepheid's website at www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software.  A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.

Interested participants and investors may also listen to the live teleconference call by dialing (866) 788-0538 (domestic) or (857) 350 1676 (international), and entering participant code 51795047.  A replay will be available for seven days beginning at 4 p.m. Pacific Time.  Access numbers for this replay are (888) 286-8010 (domestic) and (617) 801-6888 (international), with passcode 72854495.

About CepheidBased in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets.  The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures.  The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges.  Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market.  See http://www.cepheid.com for more information.CONTACTS:For Media Inquiries:For Investor Inquiries:Jared TiptonJacquie RossCepheid Corporate CommunicationsCepheid Investor RelationsTel: (408) 400 8377Tel: (408) 400 8329jared.tipton@cepheid.cominvestor.relations@cepheid.com
'/>"/>

SOURCE Cepheid
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Cepheid to Webcast Upcoming Financial Presentations
2. Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations
3. Cepheid Schedules 2009 Third Quarter Financial Results Announcement and Webcast
4. Cepheid Schedules 2009 Second Quarter Financial Results Announcement and Webcast
5. Cepheid Announces Symposium Speakers and Program Highlights for 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
6. Cepheid Reports 2009 First Quarter Results
7. Cepheid Schedules Fiscal 2009 First Quarter Financial Results Announcement and Webcast
8. Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB)
9. Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
10. Cepheid to Webcast Upcoming Financial Presentations
11. Cepheid Accelerates Direct Sales Channel in UK With Pending Acquisition of Medical Distributor Stretton Scientific
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... SAN DIEGO , Jan. 17, 2017 /PRNewswire/ ... Diego School of Medicine and St. Boniface Hospital ... treatments for peripheral neuropathy, an unmet health need ... in the Journal of Clinical Investigation, their results ... properties that prevent and reverse neuronal injury in ...
(Date:1/17/2017)... Jan. 17, 2017  Zimmer Biomet Holdings, Inc. (NYSE ... full-year 2016 sales and earnings conference call will be ... 2017, at 8 a.m. Eastern Time.  A news release ... available at 7:30 a.m. Eastern Time the morning of ... can be accessed via Zimmer Biomet,s Investor Relations website ...
(Date:1/17/2017)... YORK , Jan. 17, 2017 ... health coaching, is the first to offer fully ... obesity. Noom,s Spanish diabetes prevention and ... the reach and accessibility of lifestyle interventions among ... developing these conditions. Noom,s robust food database, program-specific ...
(Date:1/17/2017)... NEW YORK , Jan. 17, 2017  Only ... companies put patients over profits, while only 16 percent ... PollĀ® study released today. Meanwhile, 36 percent of U.S. ... nurses) put patients over profits, compared to hospitals (23%). ... health care maelstrom," said Wendy Salomon , vice ...
Breaking Biology Technology:
(Date:1/12/2017)... , January 12, 2017 A new report by Allied Market ... the global biometric technology market is expected to generate revenue of $10.72 billion by ... Continue Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
(Date:1/6/2017)... 2017  Privately-held CalciMedica, Inc., announced that it ... of a novel calcium release-activated calcium (CRAC) channel ... Acute pancreatitis, sudden painful inflammation of ... can be very serious.  In severe cases it can ... hospital stays, time in the ICU and substantial ...
(Date:1/4/2017)... , Jan. 4, 2017  For the thousands of attendees at ... global leader in connected health and biometric measurement devices and services, will ... On display in A&D Medical,s special CES Exhibit Suite ... the ongoing expansion of the company,s WellnessConnected product platform.  ... ...
Breaking Biology News(10 mins):